Anti-diabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation Researchers from the Center for Computational Science (CCS) with their collaborators from Harvard, The Scripps Research Institute, and Yale have just published a study, "Anti-diabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation" in the prestigious journal Nature that may lead to the development of novel, safer,...
Read More